| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.7M | +407.9% |
| Cost of Revenue | $1.9M | +204.2% |
| R&D Expense | $1.3M | -48.3% |
| SG&A Expense | $3.6M | +54.0% |
| Operating Income | -$2.1M | +53.1% |
| Pre-tax Income | -$3.0M | +33.8% |
| Net Income | -$3.0M | +33.8% |
| EPS (Basic) | -$0.23 | +37.8% |
| EPS (Diluted) | -$0.23 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | +181.0% |
| Accounts Receivable | $962K | +1503.2% |
| Current Assets | $17.3M | +1144.6% |
| Total Assets | $19.4M | +404.8% |
| Current Liabilities | $705K | +12.5% |
| Total Liabilities | $1.5M | -3.8% |
| Stockholders' Equity | $17.9M | +686.3% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | +66.8% |
| Capital Expenditures | $161K | -50.0% |
| Investing Cash Flow | -$161K | +50.0% |
| Financing Cash Flow | $15.8M | — |
| Free Cash Flow | -$1.3M | +65.3% |
| +37.8% |